Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) FCF Margin: 2012-2024

Historic FCF Margin for Amphastar Pharmaceuticals (AMPH) over the last 13 years, with Dec 2024 value amounting to 23.55%.

  • Amphastar Pharmaceuticals' FCF Margin rose 48.00% to 24.62% in Q3 2025 from the same period last year, while for Sep 2025 it was 15.66%, marking a year-over-year decrease of 786.00%. This contributed to the annual value of 23.55% for FY2024, which is 99.00% up from last year.
  • Per Amphastar Pharmaceuticals' latest filing, its FCF Margin stood at 23.55% for FY2024, which was up 4.40% from 22.55% recorded in FY2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' FCF Margin peaked at 23.55% during FY2024, and registered a low of 6.69% during FY2020.
  • Over the past 3 years, Amphastar Pharmaceuticals' median FCF Margin value was 22.55% (recorded in 2023), while the average stood at 19.72%.
  • In the last 5 years, Amphastar Pharmaceuticals' FCF Margin plummeted by 306bps in 2022 and then surged by 950bps in 2023.
  • Over the past 5 years, Amphastar Pharmaceuticals' FCF Margin (Yearly) stood at 6.69% in 2020, then spiked by 942bps to 16.11% in 2021, then plummeted by 306bps to 13.06% in 2022, then surged by 950bps to 22.55% in 2023, then spiked by 99bps to 23.55% in 2024.